Mark Stenhouse - Net Worth and Insider Trading
Mark Stenhouse Net Worth
The estimated net worth of Mark Stenhouse is at least $5 Million dollars as of 2024-12-28. Mark Stenhouse is the COO of Prometheus Biosciences Inc and owns about 14,000 shares of Prometheus Biosciences Inc (RXDX) stock worth over $3 Million. Mark Stenhouse is also the President, Cologuard of Exact Sciences Corp and owns about 29,926 shares of Exact Sciences Corp (EXAS) stock worth over $2 Million. Details can be seen in Mark Stenhouse's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Stenhouse has not made any transactions after 2021-03-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark Stenhouse
Mark Stenhouse Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Stenhouse owns 3 companies in total, including Exact Sciences Corp (EXAS) , Phathom Pharmaceuticals Inc (PHAT) , and Prometheus Biosciences Inc (RXDX) .
Click here to see the complete history of Mark Stenhouse’s form 4 insider trades.
Insider Ownership Summary of Mark Stenhouse
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EXAS | Exact Sciences Corp | 2020-04-03 | President & Cologuard |
| PHAT | Phathom Pharmaceuticals Inc | 2020-03-17 | director |
| RXDX | Prometheus Biosciences Inc | 2021-03-16 | Chief Operating Officer |
Mark Stenhouse Latest Holdings Summary
Mark Stenhouse currently owns a total of 2 stocks. Among these stocks, Mark Stenhouse owns 14,000 shares of Prometheus Biosciences Inc (RXDX) as of March 16, 2021, with a value of $3 Million and a weighting of 61.91%. Mark Stenhouse also owns 29,926 shares of Exact Sciences Corp (EXAS) as of April 3, 2020, with a value of $2 Million and a weighting of 38.09%.
Latest Holdings of Mark Stenhouse
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RXDX | Prometheus Biosciences Inc | 2021-03-16 | 14,000 | 199.92 | 2,798,880 |
| EXAS | Exact Sciences Corp | 2020-04-03 | 29,926 | 57.55 | 1,722,241 |
Holding Weightings of Mark Stenhouse
Mark Stenhouse Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Stenhouse has made a total of 1 transactions in Prometheus Biosciences Inc (RXDX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Prometheus Biosciences Inc is the acquisition of 14,000 shares on March 16, 2021, which cost Mark Stenhouse around $266,000.
According to the SEC Form 4 filings, Mark Stenhouse has made a total of 2 transactions in Exact Sciences Corp (EXAS) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Exact Sciences Corp is the sale of 11,948 shares on April 3, 2020, which brought Mark Stenhouse around $677,332.
Insider Trading History of Mark Stenhouse
- 1
Mark Stenhouse Trading Performance
GuruFocus tracks the stock performance after each of Mark Stenhouse's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark Stenhouse is 28.91%. GuruFocus also compares Mark Stenhouse's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark Stenhouse within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark Stenhouse's insider trading performs compared to the benchmark.
Performance of Mark Stenhouse
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 13 | | | | | |
| Relative Return to S&P 500(%) | 7.38 | | | | | |
Mark Stenhouse Ownership Network
Mark Stenhouse Owned Company Details
What does Exact Sciences Corp do?
Who are the key executives at Exact Sciences Corp?
Mark Stenhouse is the President & Cologuard of Exact Sciences Corp. Other key executives at Exact Sciences Corp include director & Vice President Kevin T Conroy , Gen. Mgr. & Precision Oncology Brian Baranick , and General Manager & New Ventures Jacob A Orville .
Exact Sciences Corp (EXAS) Insider Trades Summary
Over the past 18 months, Mark Stenhouse made no insider transaction in Exact Sciences Corp (EXAS). Other recent insider transactions involving Exact Sciences Corp (EXAS) include a net sale of 20,284 shares made by Sarah Condella , a net sale of 11,459 shares made by Brian Baranick , and a net sale of 40,200 shares made by Jeffrey Thomas Elliott .
In summary, during the past 3 months, insiders sold 929 shares of Exact Sciences Corp (EXAS) in total and bought 19,500 shares, with a net purchase of 18,571 shares. During the past 18 months, 162,623 shares of Exact Sciences Corp (EXAS) were sold and 19,500 shares were bought by its insiders, resulting in a net sale of 143,123 shares.
Exact Sciences Corp (EXAS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Exact Sciences Corp Insider Transactions
Mark Stenhouse Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Stenhouse. You might contact Mark Stenhouse via mailing address: 5505 Endeavor Lane, Madison Wi 53719.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
